You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Patent: 9,044,459

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,044,459

Title:	Method for the treatment of neurodegenerative diseases
Abstract:	Disclosed are methods for treating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Alzheimer\'s Disease Parkinson\'s Disease, Myasthenia Gravis, Multifocal Motor Neuropathy, Primary Lateral Sclerosis, Spinal Muscular Atrophy, Kennedy\'s Disease, and Spinocerebellar Ataxia.
Inventor(s):	Perrin; Steven (Newbury, MA), Lincecum; John Monteith (Jamaica Plain, MA), Gill; Alan (Reading, MA), Vieira; Fernando (Boston, MA)
Assignee:	ALS THERAPY DEVELOPMENT INSTITUTE (Cambridge, MA)
Application Number:	13/858,667
Patent Claims:	see list of patent claims

Details for Patent 9,044,459

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Bristol-myers Squibb Company	ORENCIA	abatacept	For Injection	125118	12/23/2005	⤷ Try a Trial	2028-12-05
Bristol-myers Squibb Company	ORENCIA	abatacept	Injection	125118	07/29/2011	⤷ Try a Trial	2028-12-05
Bristol-myers Squibb Company	ORENCIA	abatacept	Injection	125118	06/07/2016	⤷ Try a Trial	2028-12-05
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.